sitemap
-
home
- home page
- resources
-
featured articles
- 3 quick tips to design your hdr donor oligo for maximum efficiency
- 4 great reasons for working with lentiviral micrornas
- 4 things to know about your system for successful fluorescent protein tagging
- a day late and an shrna short how to avoid a lowpower rnai screen
- a lethal positive control for crispr knockout
- a multiparametric highcontent arrayed crispr screen for cell cycle regulators
- a role for modified synthetic rna oligos in structural studies
- a whole new way to do functional genomics screens
- a wide variety of murine research products at your fingertips
- all in one sgrna for crispr experiments
- all of the latest scientific posters for gene editing in one place
- alternative mirna design for therapeutic rnai applications
- another dnafree cas9 expression option is here
- arrayed lentiviral crispr screening not so fast lessons learned from rnai
- arrayed synthetic crispr rna screen in primary t cells validates hiv host factors
- benefits of cell panel and functional genomic screens in drug discovery
- beta tool p value to z score calculator
- calculate percent gene editing with our t7ei calculator beta tool
- choosing the right cas9 nuclease
- considerations for setting up rt qpcr experiments for gene expression studies
- considerations for t7 endonuclease i t7ei mismatch assays
- crispr cas9 gene editing workflows
- crispr cas9 guide rnas and the innate immune response
- crispr goes green crispr cas9 in plants
- crispra cdna or orf
- crispra downstream effects now it gets interesting
- custom rna you can see
- custom synthesis resources
- dCas9 VPR mRNA for quick transcriptional activation and enrichment in any cell line
- design considerations for synthetic crrna molecules
- dharmacon editr crispr cas9 gene engineering system
- dharmacon smartvector lentiviral shrnas are updated and guaranteed
- dharmacons nature reviews genetics poster
- discover novel gene functions and interactions
- doing crisprcas9 gene editing experiments here are your negative controls
- editing guaranteed with predesigned edit r guide rnas
- editr fluorescent cas9 nuclease mrna named a top 10 innovation
- editr hdr donor designer for ssdna templates
- editr hdr plasmid donors for reporter knock in
- editr lentiviral sgrnas arrayed glycerol stock libraries
- effective controls for gene editing
- enhance dna delivery to your cells while mitigating cell death
- expanded epigenetics library gene coverage
- find the best conditions for your gene editing experiment
- forward genetics new tools in functional genomic screening
- four steps to optimizing your shrna construct
- frontiers in rnai ebook
- functional knockout of a microrna using crispr cas9
- gene family libraries for ccsb broad lentiviral orfs
- get to know more about rna interference in this fun little poster
- got questions
- high throughput functional genomics screen using an edit r crrna library
- higher cas9 expression correlates gene editing efficiency
- how do we ensure the bacterial glycerol stock clones you order are alive before we ship them
- how much crrna do I need
- identification of genes involved in autophagy by rnai and high throughput imaging
- improve your data analysis with bioit beta tools
- increase the throughput and reproducibility of your crispr cas9 screen
- interested in an easier way to create knock ins
- introducing the cherrypick plater for vectorbased reagents
- introduction of our crispr screening data analysis services
- is it time for a new microscope to view your fluorescent knock in cells
- is your antibody binding the right target
- learn how screening empowers discovery
- looking to optimize the delivery of rna for crispr cas9 gene editing or rnai
- microinjection of zebrafish embryos
- more species more lengths
- multiplexed hdr knockin yes you can
- mythbusting single vs two part synthetic guide rnas
- new crispr one gene per well screening tools
- optimize your transfections with the cytell cell imaging system
- our patented 2 ace chemistry enables advanced rna synthesis
- predesigned guide rna from the editr crispr rna algorithm
- pro tips for a successful transfection
- products and information for your gene are only a click away
- proper assessment of gene editing with dna mismatch detection assays
- protect your precious pellet
- publish your gene editing results with a trusted partner
- saccharomyces cerevisiae yeast one of the oldest and most powerful genetic models
- see the capabilities dharmacon brings to your research
- sirna screening development of hit stratification strategies
- sirna to pool or not to pool
- smartchoice inducible shmimic lentiviral microrna
- smartvector lentiviral shrna and shmimic lentiviral micrornas are now available in pooled screening
- strategies to detect and validate your crispr gene edit
- synthetic guide rnas for next generation genome mapping
- take a look at our cherrypick rnai library plater
- take control of the timing of your gene editing experiment
- the accell sirna advantage
- the basics about lentiviral packaging safety features
- the dharmacon rnai application guide
- the edit r custom hdr plasmid donor kit
- the history and key scientific contributions of dharmacon
- the mathematics behind dna mismatch detection assays
- the versatility of synthetic crispr cas9 guide rna
- three reasons why you may need an arrayed crrna library
- top 4 ways to make your sirna experiment a success
- top 5 reasons to use algorithm designed guide rna
- top five considerations for orf selection
- use rnai to guide our use of crispr cas9 technology
- using field programmable gate arrays fpgas to improve sequence alignment efficiency
- using orfs with variable stop positions
- variant specific knockdown by sirna
- what is crispra vs crispri
- why you should use 3d models for high throughput screening
- world class rna research in colorado past present and future
- xenopus laevis orfeome
- you can design custom crispr rna with the dharmacon crispr design tool
- exome data
-
gated landing page
- appnote-3d-cell-panel-screen
- biop-brochure
- cell-line-engineering-brochure
- cell-line-engineering-brochure-ddnews-june-2020
- maren test 2
- outsourcing-screen-brochure
- Outsourcing-screen-brochure-dtr-eblast-june-2020
- outsourcing-screen-brochure-nature-june-2020
- sgrna-webinar-may-dtr-banner-july-2020
- webinar-leveraging-advances-in-predesigned-synthetic-sgRNA
-
publications
- safety data sheets
-
videos
- advantages-of-horizons-crispr-cas9-tools-for-gene-editing
- basic-rna-resuspension
- choosing-a-dharmacon-sirna-product-line-and-format
- crispr-cas9-screening
- crispr-design-tool-for-hdr
- crispr-design-tool-library-of-custom-guide-rnas
- crispr-series-p0-crispr-background
- designing-a-custom-gene-targeting-guide-rna-with-the-crispr-design-tool
- dharmafect-duo-for-simultaneous-delivery-of-rna-and-dna
- edit-r-crispr-cas9-experiment-design
- edit-r-crispr-cas9-gene-engineering-platform
- edit-r-hdr-dna-donor-designer-plasmid-design
- edit-r-hdr-donor-designer-tutorial-for-dna-insertion
- edit-r-hdr-donor-designer-tutorial-for-dna-removal
- edit-r-hdr-donor-designer-tutorial-for-dna-replacement
- how-to-measure-viral-titer-using-fluorescent-colony-counting
- how-to-use-the-cherry-pick-rnai-library-plater
- quick-tip-how-to-calculate-viral-titer
- quick-tip--how-to-import-gene-symbols-into-excel
- quick-tip-speed-up-spin-column-purification
- see-how-to-request-a-quote
- top-consideratins-for-rnai-and-crispr-cas9
-
safety data sheets
-
featured articles
-
videos
-
webinars
- webinars
- addressing-the-pre-pcr-analytical-variability-of-ffpe-samples
- addressing-the-variability-of-molecular-assays
- advancing cancer drug development using 2D and 3D cell panel screens
- analyzing-the-combination-effects-of-multi-drug-interventions
- arrayed-crispr-libraries-for-high-throughput-functional-genomics
- a-virtual-workshop-for-precise-hdr-mediated-genome-engineering-with-crispr-cas9
- a-workflow-for-crispr-cas9-high-throughput-arrayed-screening-with-synthetic-crrna
- crispra-tools-for-transcriptional-activation-studies
- crispr-cas9-from-reagent-selection-to-experimental-optimization
- crispr-cas9-gene-editing-with-synthetic-rna-from-start-to-finish
- crispr-engineered-human-cell-lines-and-types-of-genomic-modifications
- crispr-screening-from-target-selection-to-patient-stratification
- crispr-screening-in-primary-human-t-cells-extending-cell-type-capabilities
- crispr-screening-what-why-and-how
- exploring-inducible-systems-to-inactivate-wildtypes
- gene-editing-and-RNAi-in-primary-human-immune-cells
- getting-started-with-shrna-considerations-recommendations
- getting-started-with-sirna-considerations-recommendations
- high-throughput-crispr-cas9-genome-engineering-in-primary-t-cells
- high-throughput-genome-wide-rnai-screens-insights-from-the-sheffield-rnai-screening-facility
- how-crispr-cas9-screening-will-revolutionize-your-drug-development-programs
- how-to-identify-key-genes-with-crispr-cas9-and-shrna-screens
- how-to-use-crispr-cas9-for-knockout-knockin-and-gene-activation
- how-to-validate-and-verify-the-accuracy-of-your-clinical-laboratory-procedures
- improve-crispr-cas9-experiments-with-rationally-designed-guide-rnas
- improving-cell-based-assays-and-their-future-in-drug-discovery
- leveraging-advances-in-predesigned-synthetic-sgrnas
- optimizing-homologydirected-repair-hdr-results-with-crisprcas9
- phenotypic-crispr-screening-beyond-cell-viability
- power-up-crispri-and-crispra-tools-for-genome-wide-screening
- pro-active-cho-cell-line-development-for-bioproduction
- resolving-ambiguity-in-target-id-screens-crispr-cas9-based-essentiality-profiling
- systematic-application-of-the-crispr-toolkit
- the-effect-of-formalin-on-clinical-diagnostics
- tools-for-knockdown-of-long-noncoding-rna
- understanding-and-controlling-for-sample-and-platform-biases-in-ngs-assays
- using-reference-standards-to-validate-your-ngs-oncology-workflow
- sitemap
- about-us
- account
- applications
-
cell-line
- antibody-validation
- autophagy-pathway
- bromodomain-containing-proteins
- caspases
- cell-lines-by-research-area
- deubiquitinating-enzymes-dubs
- dna-damage-pathways
- drug-targets
- epigenetics
- histone-acetylation
- kinase-inhibition
- mtor-pathway
- parkinsons-disease
- phosphoinositide-function
- phospholipases
- rab-gtpases
- serine-threonine-phosphatase
- sialylation-pathway
- solute-carrier-slc-gene
- sumoylation
- tnf-alpha-tnfa
- ubiquitin-conjugating-enzymes
-
crispr cas9
- crispr cas9 gene editing applications
- crispr cas9 guide rna functionality
- crispr cas9 guide rna specificity
- engineering a knockout cell line
- homology directed repair with a dna donor oligo
- homology directed repair with a plasmid donor
- inducible lentiviral cas9 nuclease
- multiplex crispr cas9 knockout
- screening validation and follow up using engineered cell lines
- synthetic lethality
-
crispra
- custom rna synthesis
-
functional genomic screening
- gene expression applications
- primary cells
-
rnai
- cart
- brands
- contact us
- events
- 11th annual biomarkers congress 2016
- 12th microsymposium on small rna biology
- 13th transgenic technology meeting 2016
- 14th transgenic technology meeting tt2017
- 16th human proteome organisation world congress hupo
- 2015 society for laboratory automation and screening
- 2018 ncri cancer conference
- 2020 bpi europe virtual conference
- 20th Annual Colorado Immunology Conference
- 28th eortc nci aacr symposium 2016
- 3rd annual genome editing engineering conference
- 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress
- 4th annual neuroscience rd technologies conference
- 4th annual precision crispr congress boston
- 69th aalas national meeting 2018
- 6th annual cell culture bioprocessing congress
- 7th annual cell culture bioprocessing congress 2018
- aacr annual meeting 2018
- aacr annual meeting 2019
- AACR Annual Meeting 2020
- aacr cancer immunotherapy conference
- aacr nci eortc international conference on molecular targets and cancer therapeutic
- acmg 2016
- advances in cell based screening 2017 elrig 17
- advances in cell engineering imaging and screening
- advances in genome biology and technology 2016
- american association of cancer research aacr 2015
- american association of cancer research aacr 2016
- american association of cancer research aacr 2017
- american society of cell biology
- amp 2015 annual meeting
- amp 2017 annual meeting
- amp annual meeting 2018
- antibody validation meeting 2018
- ascb embo 2017 meeting
- ascb embo 2018 meeting
- ashg 2018 annual meeting
- association for molecular pathology annual meeting 2016 amp16
- association for molecular pathology global congress amp 2017
- bioeurope autumn 2015
- biojapan 2017
- biomarker summit 2016 gtcbio
- bioprocess international conference exhibition
- bioprocess international conference exhibition 2016
- bioprocessing summit
- bioproduction congress 2018
- bioproduction congress mammalian and microbial biopharmaceutical manufacturing
- biopronet 2018
- biotechnica
- BPI West 2020 - Cell Line Development and Engineering
- british society for cell biology british society for developmental biology
- cancer research oncology 2016
- cap16 the pathologists meeting
- cell biology 2016 ascb annual meeting
- cell culture downstream world congress 2017
- cell culture world congress 2016
- cell line development and engineering 2019
- cell line development engineering 2018
- creating a crispr community the sanger institute astrazeneca conference 2016
- crispr 2015 oxford symposium
- crispr 2018 lithuania
- crispr precision gene editing congress 2016
- edinburgh bioquarter annual conference 2015 horizons in drug discovery
- ELRIG - CRISPR in Drug Discovery 2020
- elrig drug discovery 2016
- elrig forum
- elrigfr 2015 brussels conference
- elrigs drug discovery 2018
- Engineering the Genome - Keystone Symposia
- esact uk 26th annual meeting 2016
- euromabnet 2018
- european congress of pathology 2016 ecp
- Festival of Biologics Oct 15-17 2019 Basel
- genetics and genomics 2016
- genome editing 2018 libpubmedia
- genome engineering and synthetic biology tools and technologies
- genome engineering the crisprcas revolution
- genomic and synthetic biology series us 2019
- gsn 2018
- hanson wades 9th annual clinical biomarker world cdx summit
- haploday 2016
- horizon discovery one day masterclass series crispr screening
- indian seminar series
- labroots cancer research oncology 2017
- labroots cell biology 2017
- labroots crispr 2018
- labroots genetics and genomics 2018
- labroots laboratory animal sciences 2018
- media event gene editing day 2016
- molecular diagnostics 2016
- molecular med tri con 2016
- molecular med tri con 2019
- molecular medicine tri con 2017
- ncri cancer conference 2016
- neuroscience 2016 sfn
- nordiqc conference on applied immunohistochemistry
- oxford global genome editing usa congress 2018
- pegs boston
- peptalk the protein science week
- precision lbx 2018
- precision lbx summit 2017
- precision medicine 2016
- precision medicine world conference 2018 pmwc 2018
- precision medicine world conference 2019 pmwc 2019
- rna societys 23rd annual meeting 2018
- screening strategies to advance discovery in therapeutic development and drug target identification
- seminar genome editing in human cells using crisprcas9
- sfns 47th annual meeting neuroscience 2017
- sfns 48th annual meeting neuroscience 2018
- slas 2018
- slas society for lab automation and screening 2017
- society for laboratory automation and screening 2016
- society for neuroscience neuroscience 2015
- society of toxicology annual meeting 2017
- sot 2015
- sot 57th annual meeting and toxexpo
- tata memorial platinum jubilee conference
- the 14th european issx meeting 2017
- the 15th transgenic technology meeting tt2019
- the crispr forum 2017 crispr drug discovery tool or therapeutic revolution
- the crispr forum 2018
- The Festival of Biologics
- the society of toxicology 55th annual meeting and toxexpo
- tides oligonucleotide and peptide therapeutics 2018
- toxexpo sot 2019
- tumor models 2015
- tumor models boston 2017
- uscap 2016
- world cdx boston 2016
- world cdx boston 2017
- world cdx europe
- world cdx europe 2017
- world cdx regulation
- AMP 2019 Annual Meeting and Expo
- Cell Culture and Bioprocessing
- International Biotechnology Congress Singapore 2019
- Labroots CRISPR October 3rd 2019
- eprocurement
- FAQ
- legal
- navigation
- news
-
2020
-
2019
- Horizon Discovery divests animal models business to Envigo
- Horizon Discovery introduces predesigned synthetic sgRNAs
- Horizon Discovery partners with the Human Protein Atlas
- Horizon Discovery signs license agreement with Glenmark
- Horizon Discovery SMARTvector shRNA technology deployed in Celyad successful IND
- Horizon Discovery to collaborate with St Georges University Hospital and EMQN
-
2018
- Edit R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform
- Horizon Discovery appoints Terry Pizzie as Chief Executive Officer
- Horizon Discovery colloboration pharmaceutical company on single cell RNAseq linked CRISPR screening
- Horizon Discovery Enters into License Agreement with US Immuno Oncology Company
- Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia
- Horizon Discovery introduces whole human genome arrayed libraries for CRISPR activation screening
- Horizon Discoverys Bioproduction cell line used as part of a successful drug IND filing
- Horizon enters into partnership with Pirbright Institute to support improvement of vaccine yields
- Horizon Genewell Biotechnology partner for distribution of reference standards for Chinese market
- Horizon partners with Biocartis reference standards for Idylla microsatellite instability assay
- Preliminary Results for the Year Ended 31 December 2017
-
2017
- 2016 Trading Update
- Abcam plc Exercises Exclusivity Provision of License and Supply Agreement with Horizon Discovery
- ATUM and Horizon Discovery Announce Collaboration to Simplify Speed Cell Line Development
- Dharmacon introduces Edit R CRISPRa reagent platform for genomewide CRISPR activation
- Generation Genome A Horizon Discovery comment on the UK Chief Medical Officers 2016 annual report
- Horizon broadens gene editing capabilities through extension of key CRISPR license
- Horizon Discovery Announces Gene Editing Technology Platform for Research Therapeutic Applications
- Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval
- Horizon Discovery Announces Progress of its Gene and Cell Therapy Platform
- Horizon Discovery announces release of high quality well annotated CHO genome sequence
- Horizon Discovery enters into agreement with Roche Diagnostics
- Horizon Discovery enters into RD and licensing partnership with Amplycell SA
- Horizon Discovery Exclusive License for Novel Transposon Based Gene Editing Technology Platform
- Horizon Discovery Group Comment on the Acquisition of Agalimmune by BioLineRx
- Horizon Discovery introduces Multiplex cfDNA Reference Standard for EGFR mutations
- Horizon Discovery introduces OncoSpan the worlds largest DNA multiplex Reference Standard
- Horizon Discovery launches Genome Wide CRISPRi and CRISPRa Screening Services
- Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma
- Horizon Discovery partners The Michael J Fox Foundation preclinical models for Parkinsons Disease
- Horizon Discovery Signs a Master Service Agreement with a Top Three Pharmaceutical Company
- Horizon Discoverys knockout rat models paving the way for Autism drugs that actually work
- Horizon Discoverys RNA reference standards endorsed by Thermo Fisher Scientifics White Paper
- Horizon Enters in Agreement Global Molecular Diagnostics Provider for Non Invasive Prenatal Testing
- Horizon extends industry leading gene editing IP portfolio through expansion of CRISPR license right
- International Trade Minister Greg Hands visits fast growing Cambridge life sciences company
- Site Visit
- Structural Multiplex Reference Standard now available in FFPE
-
2016
- ArcherDX Launches SureShot Triple Fusion Positive NGS Control
- Horizon and Ubiquigent Enter into Collaboration Agreement
- Horizon Discovery and CareDx in OEM Agreement for Inclusion of Cell Free DNA Reference Standards
- Horizon Discovery Announces a Progress Update on its Biomanufacturing Business
- Horizon Discovery Announces a Progress Update on its Cell Line Catalogue Business
- Horizon Discovery Announces a Progress Update on its High throughput Molecular Screening Platform
- Horizon Discovery cofounder Alberto Bardelli President European Association for Cancer Research
- Horizon Discovery Enters Chinese Clinical Diagnostics Market
- Horizon Discovery fastest growing UK based life science company Deloitte Technology Fast 500 EMEA
- Horizon Discovery Group and Ventana Medical Systems Sign Co development Agreement
- Horizon Discovery Group plc Director PDMR Shareholding
- Horizon Discovery Group plc hosts symposium on gene editing
- Horizon Discovery Group plc Launches HDx RNA Fusion Reference Standards
- Horizon Discovery Introduces High Throughput Platform for Immuno Oncology Research
- Horizon Discovery introduces Microinjection Ready Cas9 Accelerate Ribonucleoprotein
- Horizon Discovery Licenses Biomanufacturing Cell Lines to CPI and NIBRT
- Horizon Discovery Partners with Sophia Genetics on NGS Reference Standards for Oncology Applications
- Horizon Discovery product included in The Scientist Top 10 Innovations list for fourth year running
- Horizon Discovery Ranked 41st Fastest Growing Tech Company in UK 2016 Deloitte Technology Fast 50
- Horizon Discovery Signs License Agreement with ProteoNic BV
- Horizon Discovery Signs Subscription Based Licensing Agreement for Biomanufacturing Cell Lines
- Horizon Discovery Takes Exclusive License to a Range of Melanoma Patient Derived Xenograft Models
- Horizon Enters into OEM Agreements with Market Leading Next Generation Sequencing Company
- Immuno Oncology Therapeutic Development and Joint Venture with Centauri Therapeutics
- Interim Results for the Six Months Ended 30 June 2016
- Notice of Interim Results
- Preliminary Results for the Year Ended 31 December 2015
-
2015
- 2014 Annual Report and Accounts and AGM Notification
- Horizon appoints Mr Grahame Cook as a Non Executive Director
- Horizon Discovery CEO Darrin Disley wins Entrepreneur of the Year 2015
- Horizon Discovery Group plc Trading Update
- Horizon Discovery Group plc Acquires Haplogen Genomics GmbH
- Horizon Discovery Group plc and Abcam plc Sign License and Supply Agreement
- Horizon Discovery Group plc and ArcherDX Sign OEM Agreement
- Horizon Discovery Group plc and Axol Bioscience Ltd announce strategic partnership
- Horizon Discovery Group plc and DefiniGEN Collaboration to Develop Gene Engineered iPS Cell Lines
- Horizon Discovery Group plc and Desktop Genetics Launch gUIDEbook Bioinformatics Software
- Horizon Discovery Group plc and Partners Awarded up to 6M Funding Supply Chain Initiative
- Horizon Discovery Group plc and Redx Pharma plc Sign Cancer Research Collaboration
- Horizon Discovery Group plc and Thermo Fisher Scientific Sign Supply and Commercialisation Agreement
- Horizon Discovery Group plc Centre for Process Innovation and University of Manchester Awarded 2M
- Horizon Discovery Group plc Enters Bioproduction Cell Line Licensing Agreement with LakePharma Inc
- Horizon Discovery Group plc Introduces Range of Immunohistochemistry HDx Reference Standards
- Horizon Discovery Group plc Launches New ECommerce Platform and Expands UK Headquarters
- Horizon Discovery Group plc Named Business of the Year at Business Weekly Awards
- Horizon Discovery Group plc signs three diagnostic agreements worth an initial 3 million
- Horizon Discovery Group plc to Invest up to 10 Million of Funding to Identify Cancer Therapeutics
- Horizon Discovery Group plc to Support Cancer Research UKs Stratified Medicine Program
- Horizon Discovery Group plc Trading Update
- Horizon Discovery introduces Cell Free DNA HDx Reference Standards
- Horizon Discovery Partners with Swift Biosciences on Genomic Reference Standards
- Horizon Discovery Selected as Core Facility by Tri Institutional Therapeutics Discovery Institute
- Notice of Preliminary Results
- Transgenomic to use Horizon Discovery Reference Standards into Multiplexed ICE COLD PCR kits
- Unaudited Preliminary Results for the Year Ended 31 December 2014
-
2014
- Horizon Discovery Adds Three Eminent CRISPR Experts to its Scientific Advisory Board
- Horizon Discovery and LGC Awarded Technology Strategy Board Grant to Develop Standardization
- Horizon Discovery and Otsuka Pharmaceutical Development and Commercialization Sign Agreement
- Horizon Discovery and Transgenomic Announce Collaboration Genetic Diagnostic Tests
- Horizon Discovery Announces Oncology Research Collaboration with AstraZeneca
- Horizon Discovery CEO Darrin Disley wins Executive of the Year award at the SCRIP Awards 2014
- Horizon Discovery Establishes Scientific Advisory Board for Horizon Diagnostics Business Unit
- Horizon Discovery Group plc
- Horizon Discovery Group plc Acquires Sage Labs Inc for 48M
- Horizon Discovery Group plc Acquisition of CombinatoRx Service Business and Assets from Zalicus
- Horizon Discovery Group plc and Adarza BioSystems Enter Supply and Licensing Agreement
- Horizon Discovery Group plc Announces Intention to Float
- Horizon Discovery Group plc Appoints Dr David Smoller as an Executive Director
- Horizon Discovery Group plc Raises 68 million
- Horizon Discovery Group plc Re Share Price Movement
- Horizon Discovery Group plc Signs Master Services Agreement for Approximately 1 million
- Horizon Discovery Group plc the Company
- Horizon Discovery Group plc to Acquire CombinatoRx Service Business and Assets from Zalicus Inc
- Horizon Discovery Group Signs Agreement with leading molecular diagnostics company for 810000
- Horizon Discovery Group Signs Agreement with Top Ten Pharma Company
- Horizon Discovery Group Signs Co Exclusive Commercial Agreement with Haplogen Genomics
- Horizon Discovery Group Signs Collaboration Agreement with Top Ten Pharma Company
- Horizon Discovery Launches GENASSIST Line of Kits and Reagents for Gene Editing
- Horizon Discovery Launches Gene Engineered Bioproduction Cell Line with Flexible Licensing Model
- Horizon Discovery Launches New GENASSIST CRISPR and rAAV Gene Editing Tools and Services
- Horizon Discovery Launches Patient Derived Xenograft Models of Breast Cancer under SAGE Labs Brand
- Horizon Discovery Licenses AAV Gene Delivery Technology from Stanford University
- Horizon Discovery Licenses CRISPR Gene Editing Technology from the Broad Institute
- Horizon Discovery Licenses CRISPRCas9 Gene Editing Technology from ERS Genomics
- Horizon Discovery Signs Distribution Agreement with Haplogen
- Horizon Discovery Signs Large Scale License Agreement for its XMAN Cell Lines in Japan
- Horizon Discovery Signs Supply and Distribution Agreement with Sirion Biotech GmbH
- Horizon Discovery Strengthens Board with Appointment of Dr Susan Galbraith and Susan Searle
- Interim Results for the Six Months Ended 30 June 2014
-
2013
- Crown Bioscience and Horizon Discovery Announce Two Year Agreement to Offer In Vivo Drug Discovery
- David Evans Steps Down as Chairman of the Board for Horizon Discovery
- Horizon Discovery and AstraZeneca win Licensing Deal of the Year at Scrip Awards 2013
- Horizon Discovery and Blueprint Medicines Enter Oncology Research Service Agreement
- Horizon Discovery and Boehringer Ingelheim Enter Oncology Research Service Collaboration
- Horizon Discovery and Desktop Genetics Collaborate on CRISPR Design Platform
- Horizon Discovery and Hisun Pharmaceuticals Partner on Gene Engineered Bioproduction Cell Line
- Horizon Discovery and RIKEN GENESIS Sign Distribution Agreement
- Horizon Discovery Announces Oncology Drug Discovery Collaboration with AstraZeneca
- Horizon Discovery Announces Series C Continuation Fundraising
- Horizon Discovery CEO Joins UKTI Delegation to India Led by David Cameron
- Horizon Discovery Establishes Three New Centers of Excellence in Asia
- Horizon Discovery Licenses CRISPR Gene Editing Technology from Harvard University
- Horizon Discovery licenses Zinc finger nuclease gene editing technology from Sigma Aldrich
- Horizon Discovery Ranked Number One Fastest Growing Biotechnology Company in the UK in the 2013 Delo
- Horizon Discovery Strengthens Board with Appointment of Dr Ian Gilham
- Horizon Discovery Wins Most Promising Company at World Conference on Personalized Medicine
- Horizon Introduces Quantitative Multiplex Genomic Reference Standards for Tumor Profiling
-
2012
- COLTHERES Identifies Molecular Signatures Leading to Personalized Therapies for Colorectal Patients
- Crown Bioscience and Horizon Discovery Showcase XMAN Cell Lines for In Vivo and In Vitro at EORTC
- Horizon and University of Leicester Form Center of Excellence in rAAV mediated Genome Editing
- Horizon and Washington University BRIGHT Institute Form Facility for rAAV mediated Genome Editing
- Horizon Discovery and ATCC Sign Global Licensing and Distribution Agreement for XMAN cell lines
- Horizon Discovery and Bayer Collaborate to Develop Cell Line Models to Support Oncology Programs
- Horizon Discovery and H3 Biomedicine collaborate to identify and validate novel cancer targets
- Horizon Discovery and NIH Center for Regenerative Medicine Collaborate to Apply rAAV Genome Editing
- Horizon Discovery and Promega Launch Suite of XMAN Reporter Kits
- Horizon Discovery and Rosalind Franklin University Develop Cystic Fibrosis Cellular Disease Models
- Horizon Discovery and UCL Institute of Neurology Collaborate in rAAV mediated Genome Editing
- Horizon Discovery Announces Board Member Simon Cook
- Horizon Discovery Appoints Chris Claxton as Marketing Manager
- Horizon Discovery Appoints Eric Rhodes as Chief Technical Officer
- Horizon Discovery Appoints Richard Vellacott as Chief Financial Officer
- Horizon Discovery Establishes Three Centers of Excellence in rAAV mediated Cellular Genome Editing
- Horizon Discovery Joins 4D Cell Fate Consortium
- Horizon Discovery launches rAAV mediated genome editing support website
- Horizon Discovery Launches SyntheTx Partnership Program for Cancer Therapeutics
- Horizon Discovery Named Business of the Year
- Horizon Discovery receives the Queens Award for Enterprise in International Trade
- Horizon Partners with EMQN to Minimise Variability in Cancer Diagnostic Testing Across Europe
-
2011
- Horizon and Fox Chase Cancer Center announce a new Centre of Excellence in Mammalian Gene Editing
- Horizon and UK NEQAS ICC Announce Partnership to Improve Accuracy of Lung Cancer Diagnostic Testing
- Horizon and Univ of Washington Announce Collaboration to Apply rAAV Gene Editing in iPS cells
- Horizon Collaboration with National Cancer and National Human Genome Research Institutes
- Horizon Discovery Announces Fundraising
- Horizon Discovery Expands Commercial Division with Appointments and Increases its UK Premises
- Horizon Discovery Introduces Panel of Molecular Diagnostic Reference Standards
- Horizon Discovery Licenses 50 New XMAN Cell Lines from Public University Corporation Yokohama City
- Horizon Licenses New XMAN Cell Lines from the Uni of Minnesota relating to Tcell viral infections
- Horizon receives grant funding from EU FP7 program and joins the COLTHERES consortium
- Horizon Secures Exclusive License from Univ of Pittsburgh to Panel of New Human Isogenic Cell Lines
- Horizon Secures Exclusive License to Homologous Recombination Inventions from Univ of Minnesota
- Horizon Successfully Completes Pilot Human Gene Editing Program With Leading Pharma
- Strategic partnership with Promega to develop next generation predictive human disease models
-
2010
- Horizon Acquires Hypoxium and Launches Horizon Discovery Services Ltd
- Horizon and Cylene Pharmaceuticals Collaborate in Rational Selection of Patients for Clinical Trial
- Horizon and ICR to Collaborate on Genome Wide Synthetic Lethality Screens
- Horizon and Mirna Therapeutics to Test Activities of Tumor Suppressor MicroRNAs in XMAN Models
- Horizon announce a series of new deals signed with leading Pharma and Biotech companies
- Horizon announces that it has been awarded 300000 grant under EUFP7 program
- Horizon Closes Series C Financing and Makes New Board Appointments
- Horizon Discovery Completes Materials Transfer Agreement with Sunesis Pharmaceuticals
- Horizon Named Bioscience Company of the Future at the Cambridge Phenomenon Conference
- Horizon Receive Eurostars Award 500000 Grant to Model Noninherited SNPs That May Drive Cancer
- Horizon Secures License from Case Western to 35 Endogenously Tagged Human Isogenic Cell Lines
- Horizon Secures license from the Univ of Minnesota to new XMAN Cell lines relating to DNA repair
- Horizon Sign New Commercial Deals with Leading Pharma Companies
- Horizon to Support 50 Centers of Excellence in Human Cellular Gene Editing
- The Translational Genomics Research Inst becomes center of excellence for GENESIS and XMAN
-
2009
- Horizon and DxS to Lead the Way in Setting Standards for Companion Diagnostic Tests in Cancer
- Horizon Appoint Dr Darrin M Disley as its New Executive Chairman
- Horizon Discovery and Biolog Inc Present Joint Data on XMAN Cancer Metabolism
- Horizon Discovery and University of Washington Expand Gene Targeting Licenses
- Horizon Discovery Announces World Leading Translational Medicine and Gene Targeting Experts
- Horizon Discovery Cofounders Work to be Showcased as Breakthrough in Cancer Research at AACR 2009
- Horizon Discovery Named 1 UK Technology Start Up and Company of the Year at iawards 2009
- Horizon Discovery Sign Agreement with Infinity Pharmaceuticals
- Horizon Discovery Sign Commercial Screening Agreement with Silicos NV
- Horizon Discovery Sign Multi Year Technology Access Agreement with Genentech Inc
- Horizon Discovery Sign Three Year Collaboration with World Leading Cancer Pharma Genentech
- Horizon Discovery Signs Technology Evaluation Agreement with Array BioPharma
- Horizon Discovery to Expand and Establish New UK Headquarters at IQ Cambridge
- Horizon Secures World Wide Exclusive License from University of Maryland on new XMAN Cell lines
- Horizon Selected for Final of World Entrepreneurship Competition
- Horizon Sign 2nd License Agreement with Ortho Biotech Oncology R and D a division of Janssen NV
- Horizon Sign Commercial Screening Agreement with SuperGen Inc
- Horizon Sign License Agreement with Ortho Biotech Oncology RD division of Janssen Pharmaceutica NV
- Horizon Sign New Technology Licensing Deal with US Pharma Giant
- Horizon Sign Worldwide Exclusive License to New Inventions from Translational Medicine Researchers
- Horizon Signs Four Year Collaboration with World Leading Pharma to Develop XMAN Cell Lines
- Inside the XMAN Crack University of Liverpool Scientists to Mine Horizons Patient Relevent Models
- Newcastle University Scientists to Develop XRay Vision for Horizon Discoverys XMAN
- X On The Beach Horizon forms Commercial Alliance with GeneWorks in Australia New Zealand
-
2008
- Horizon Closes Screening Contract with Prolexys Pharmaceuticals
- Horizon deploys GENESIS to engineer new XMAN regiments for Millennium
- Horizon Discovery and Cancer Research UK form Drug Discovery Venture
- Horizon Discovery Appoints Dr Rob Howes as R and D Director
- Horizon Discovery deploy new XMAN regiments in the fight against cancer
- Horizon Discovery Hiring Now for Gene Engineering Lab Torino Italy
- Horizon Discovery Ltd Secures Further Investment
- Horizon Discovery Ltd signs a commercial agreement with AstraZeneca UK Ltd
- Horizon Discovery Make the Final Stages of the Medical Futures Innovation Awards
- Horizon Discovery opens new Gene Engineering laboratory in Torino Italy
- Horizon Discovery Sign Agreement with Leading Cancer Pharma Millennium
- Horizon Discovery sign drug profiling alliance with Caliper Life Science
- Horizon Discovery signs drug profiling alliance with Hypoxium Ltd
- Horizon Hiring new XMEN Scientists for Cambridge and Torino Laboratories
- Horizon Secures Exclusive Patent Position on Award Winning GENESIS Platform
- Horizon Sign Agreement With Novartis Institute of Biomedical Research
- Horizon Sign Screening Agreement with Actelion Pharmaceuticals
- Horizon Sign Screening and License Agreements with Agios Pharmaceuticals
- Horizon Signs Commercial Agreement with OSI Pharmaceuticals
- Horizon to Find Drug Candidates for EU Stem Cell Consortium
-
2007
- Horizon Discovery licenses cancer cell lines to top US Cancer Pharma Genentech
- Horizon Discovery Ltd signs second commercial agreement with Genentech Inc
- Horizon Discovery signs key agreements with Cambridge Enterprise and University of Washington
- Horizon Discovery signs up commercial partner Execute Technologies Inc
- ordering-information
- quick cart page
- product inquire
- products
- covid19 research support
- Horizon and Envigo complete transaction
- contract research services
-
custom synthesis
-
diagnostic reference standards
- our partners
- shipping charges
-
PIFs
- 5 Fusion Multiplex Negative Control
- 5 Fusion Multiplex Positive Control
- AKT1 Wild Type Reference Standard
- ALK RET ROS RNA fusion
- BRAF V600E FFPE Reference Standard 50
- BRAF V600E Reference Standard 1
- BRAF V600E Reference Standard 20
- BRAF V600E Reference Standard 5
- BRAF V600E Reference Standard 50
- BRAF V600K Reference Standard 1
- BRAF V600K Reference Standard 5
- BRAF V600K Reference Standard 50
- BRAF V600R Reference Standard 50
- BRAF wild type FFPE 100
- BRAF Wild Type Reference Standard
- BRCA Germline I gDNA
- BRCA Germline II gDNA
- BRCA Somatic Multiplex I FFPE
- BRCA Somatic Multiplex I gDNA
- EGFR E746 A750 FFPE 50
- EGFR E746A750 Reference Standard 5
- EGFR E746A750 Reference Standard 50
- EGFR G719A Reference Standard 50 1 FFPE curl
- EGFR G719A Reference Standard 50 1 ug
- EGFR G719S Reference Standard 5
- EGFR G719S Reference Standard 50
- EGFR GeneSpecific Multiplex Reference Standard FFPE 1AF
- EGFR GeneSpecific Multiplex Reference Standard FFPE 5 AF
- EGFR GeneSpecific Multiplex Reference Standard gDNA
- EGFR L858R Reference Standard 5
- EGFR L858R FFPE 50
- EGFR L858R Reference Standard 20
- EGFR L858R Reference Standard 50
- EGFR L861Q Reference Standard 5
- EGFR L861Q Reference Standard 50
- EGFR Multiplex cfDNA Reference Standard Set
- EGFR S7681 FFPE 50
- EGFR S768I Reference Standard 50
- EGFR T790M gDNA 50
- EGFR T790M Reference Standard 20
- EGFR T790M Reference Standard 5
- EGFR T790M Reference Standard 50
- EGFR V769D770insASV Reference Standard 50 1 FFPE curl
- EGFR V769D770insASV Reference Standard 50 1 ug
- EGFR Wild Type Reference Standard 1 FFPE curl
- EGFR Wild Type Reference Standard 5 ug
- EML4ALK Reference Standard 50
- FLT3 D835Y Reference Standard 50
- FLT3 Wild Type Reference Standard
- Genome in a Bottle Ashkenazim PGP Father Reference Standard
- Genome in a Bottle Ashkenazim PGP Mother Reference Standard
- Genome in a Bottle Ashkenazim PGP Son Reference Standard
- Genome in a Bottle Asian PGP Son Reference Standard
- IDH1 R132H Reference Standard 50
- IDH1 Wild Type Reference Standard
- IDH2 R172K Reference Standard 50
- IDH2 Wild Type Reference Standard
- Idylla MSI Reference Standard
- Idylla MSS Reference Standard
- JAK2 V617F Reference Standard 50
- JAK2 Wild Type Reference Standard
- KRAS A59T Reference Standard 50
- KRAS G12A Reference Standard 5
- KRAS G12A Reference Standard 50 1 FFPE curl
- KRAS G12A Reference Standard 50 1 ug
- KRAS G12C Reference Standard 50 1 FFPE curl
- KRAS G12C Reference Standard 50 1 ug
- KRAS G12D Reference Standard 5
- KRAS G12D Reference Standard 50 1 FFPE curl
- KRAS G12D Reference Standard 50 1 ug
- KRAS G12R Reference Standard 50 1 FFPE curl
- KRAS G12R Reference Standard 50 1 ug
- KRAS G12S Reference Standard 50 1 FFPE curl
- KRAS G12S Reference Standard 50 1vug
- KRAS G12V Reference Standard 50 1 FFPE curl
- KRAS G12V Reference Standard 50 1 ug
- KRAS G13D Reference Standard 5
- KRAS G13D Reference Standard 50 1 FFPE curl
- KRAS G13D Reference Standard 50 1 ug
- KRAS GeneSpecific Multiplex Reference Standard FFPE
- KRAS Q61H Reference Standard 50
- KRAS Q61L Reference Standard 50
- KRAS Wild Type Reference Standard 1 FFPE curl
- KRAS Wild Type Reference Standard 5 ug
- MSI FFPE DNA Reference Standard
- MSS FFPE DNA Reference Standard
- Multiplex I cfDNA Reference Standard Set
- Multiplex I cfDNA Reference Standard Set in Synthetic Matrix
- Multiplex I cfDNA Reference Standard Set in Synthetic Plasma
- Myeloid DNA Reference Standard
- NRAS G12D Reference Standard 50
- NRAS Q61R Reference Standard 50
- NRAS Wild Type Reference Standard 1 FFPE curl
- NRAS Wild Type Reference Standard 5 ug
- OncoSpan cfDNA
- OncoSpan FFPE
- OncoSpan gDNA
- PIK3CA E542K Reference Standard 50 1 FFPE curl
- PIK3CA E542K Reference Standard 50 1 ug
- PIK3CA E545K Reference Standard 50 1 FFPE curl
- PIK3CA E545K Reference Standard 50 1 ug
- PIK3CA H1047R Genomic Reference Standard 50
- PIK3CA H1047R Reference Standard 50
- PIK3CA Wild Type Reference Standard 1 FFPE curl
- PIK3CA Wild Type Reference Standard 5 ug
- Quantitative Multiplex Reference Standard fcDNA mild
- Quantitative Multiplex Reference Standard fcDNA moderate
- Quantitative Multiplex Reference Standard fcDNA severe
- Quantitative Multiplex Reference Standard FFPE
- Quantitative Multiplex Reference Standard gDNA
- Structural Multiplex cfDNA Reference Standard
- Structural Multiplex Reference Standard FFPE
- Structural Multiplex Reference Standard gDNA
- TruQ 0 100 Wildtype Reference Standard
- TruQ 1 5 Tier Reference Standard
- TruQ 2 5 Tier Reference Standard
- TruQ 3 5 Tier Reference Standard
- TruQ 4 5 Tier Reference Standard
- TruQ 7 13 Tier Reference Standard
-
analysis technique
-
custom services and products
-
format
-
sample type
-
cho cells
-
delete legacy info
-
delete legacy info
-
gene editing
-
gene editing reagents
-
PIFs
- Edit R predesigned synthetic sgRNA
- Edit R synthetic sgRNA positive controls
- Edit R synthetic sgRNA non targeting controls
- Edit R predesigned synthetic crRNA
- Edit R synthetic crRNA positive controls
- Edit R synthetic crRNA non targeting controls
- Edit R tracrRNA
- Edit R predesigned lentiviral sgRNA
- Edit R lentiviral sgRNA positive controls and kits
- Edit R lentiviral sgRNA non targeting controls
- Edit R predesigned all in one lentiviral sgRNA
- Edit R all in one lentiviral sgRNA positive controls and detection primers
- Edit R all in one lentiviral sgRNA non targeting controls
- Cas9 nuclease mRNA
- Cas9 nuclease protein NLS
- Cas9 nuclease expression reagents
- Lentiviral Cas9 nuclease reagents
- Edit R HDR plasmid donor components
- Edit R HDR plasmid donor HA primers
- Edit R HDR plasmid donor kits
- Edit R HDR plasmid donor primers
- crispr guide rna
- cas9 nucleases
- crispr controls and detection primers
- hdr knock in templates
-
PIFs
-
cell line models
-
gene editing reagents
-
gene modulation
-
knockdown reagents
-
sirna
-
PIFs
- ON TARGETplus siRNA Reagents Human
- ON TARGETplus siRNA Reagents Mouse
- ON TARGETplus siRNA Reagents Rat
- Accell siRNA Reagents Human
- Accell siRNA Reagents Mouse
- Accell siRNA Reagents Rat
- siGENOME siRNA Reagents Human
- siGENOME siRNA Reagents Mouse
- siGENOME siRNA Reagents Rat
- Lincode siRNA Reagents Human
- Lincode siRNA Reagents Mouse
- Anti B Gal siRNA 1
- Anti Luc siRNA 1
- GFP Duplex I
- Luciferase Duplex
- Luciferase GL2 Duplex
- Luciferase GL3 Duplex
- RLuc Duplex
- siSTABLE Cyclophilin B Control siRNA Human
- siSTABLE Cyclophilin B Control siRNA Mouse
- siSTABLE GAPD Control siRNA Mouse
- siSTABLE Non targeting siRNA 1
- on targetplus sirna
- accell sirna
- sigenome sirna
- lincode sirna
-
PIFs
-
shrna
-
PIFs
- SMARTchoice Promoter Selection Plate
- SMARTvector Lentiviral shRNA
- SMARTvector Inducible Lentiviral shRNA
- SMARTvector Inducible Lentiviral Controls
- SMARTvector Indexing PCR and Sequencing Primer Kit
- Trans Lentiviral shRNA Packaging System
- GIPZ Lentiviral shRNA
- GIPZ Lentiviral shRNA Controls
- TRIPZ Inducible Lentiviral shRNA
- TRIPZ Inducible Lentiviral shRNA Controls
- TRC Lentiviral shRNA
- TRC Lentiviral shRNA Controls
- shrna
-
PIFs
-
mirna
-
controls
-
PIFs
- ON TARGETplus Cyclophilin B Control siRNA
- ON TARGETplus Cyclophilin B Control Pool
- ON TARGETplus GAPD Control siRNA
- ON TARGETplus GAPD Control Pool
- ON TARGETplus Non targeting Control siRNAs
- ON TARGETplus Non targeting Control Pool
- Accell Control siRNA Kit Green
- Accell Control siRNA Kit Red
- Accell Cyclophilin B Control siRNA
- Accell Cyclophilin B Control Pool
- Accell Green Cyclophilin B Control siRNA
- Accell Red Cyclophilin B Control siRNA
- Accell GAPD Control siRNA
- Accell GAPD Control Pool
- Accell eGFP Control siRNA
- Accell eGFP Control Pool
- Accell Non targeting Control siRNA
- Accell Non targeting Control Pool
- accell-green-non-targeting-control-sirna
- Accell Red Non targeting Control siRNA
- Lincode GAS5 Control siRNA
- Lincode GAS5 Control Pool
- Lincode Non targeting Control siRNAs
- Lincode Non targeting Pool
- miRIDIAN microRNA Hairpin Inhibitor Negative Control 1
- miRIDIAN microRNA Hairpin Inhibitor Negative Control 2
- miRIDIAN microRNA Hairpin Inhibitor Negative Control 3
- miRIDIAN microRNA Hairpin Inhibitor Negative Control 4
- miRIDIAN microRNA Hairpin Inhibitor Positive Control
- miRIDIAN microRNA Hairpin Inhibitor Transfection Control with Dy547
- miRIDIAN microRNA Mimic Endogenous Positive Control
- miRIDIAN microRNA Mimic Negative Control 1
- miRIDIAN microRNA Mimic Negative Control 2
- miRIDIAN microRNA Mimic Negative Control 3
- miRIDIAN microRNA Mimic Negative Control 4
- miRIDIAN microRNA Mimic Transfection Control with Dy547
- miRIDIAN microRNA Mimic Housekeeping Positive Control 1 PPIB
- miRIDIAN microRNA Mimic Housekeeping Positive Control 2 GAPD
- siGENOME Controls Basic Kit
- siGENOME Controls Complete Kit
- siGENOME Cyclophilin B Control siRNA
- siGENOME GAPD Control siRNA
- siGENOME Lamin A C Control siRNA
- siGENOME Non Targeting Control siRNAs
- siGENOME Non Targeting siRNA Control Pools
- siGENOME RISC Free Control
- SMARTvector Lentiviral Controls
- accell controls
- lincode controls
- miridian microrna mimic controls
- miridian mirna hairpin inhibitor controls
- on targetplus controls
- reporter genes sistable other controls
- rnai controls
- sigenome controls
- siglo controls
-
PIFs
-
sirna
-
overexpression reagents
- cdna and orfs
- cdna and orf libraries
-
crispra
-
cdna
-
orfs
-
pifs
- CCSB Broad Lentiviral Expression Collection
- CCSB Broad Lentiviral Expression Gene Family Libraries
- CCSB Broad Lentiviral Expression Library
- CCSB Human ORFeome Collection
- CCSB Human ORFeome Gene Family Libraries
- CCSB Human ORFeome Library
- hORFeome v8 1 Collection
- hORFeome V8 1 Gene Family Libraries
- hORFeome V8 1 Library
- ORFeome Collaboration Clones
- ORFeome Collaboration Library
- Precision LentiORF collection
- Precision LentiORF positive control
- Precision LentiORF gene family libraries
- Precision LentiORF whole genome expression library
- Trans Lentiviral ORF Packaging System
- ccsb human orfeome
- ccsb broad lentiviral expression library
- human orfeome v8 1
- mammalian orfs
- orfeome collaboration collection
- precision lentiorfs
-
pifs
-
non mammalian
-
PIFs
- C elegans ORF Collection
- C elegans Promoter Collection
- C elegans RNAi Collection
- C elegans Transcription Factors
- E coli Keio Knockouts
- E coli Promoter Collection
- E coli Tagged ORFs
- Molecular Barcoded Yeast MoBY ORF Library
- S cerevisiae mTn
- S cerevisiae mTn Collection
- Xenopus
- Xenopus Collection
- Yeast Barcoder Collection
- Yeast Cross and Capture System
- Yeast Cross and Capture System Collection
- Yeast DAmP
- Yeast DAmP Collection
- Yeast Genomic Tiling Collection
- Yeast GST tagged ORFs
- Yeast GST tagged ORFs Collection
- Yeast HA Tagged
- Yeast Insertional Mutant
- Yeast Insertional Mutant Collection
- Yeast Knockout
- Yeast Knockout Collection
- Yeast ORF
- Yeast ORF Collection
- Yeast Parental Strains
- Yeast Protein Interactome Collection
- Yeast Synthetic Histone H3 and H4 Mutant Collection
- Yeast TAP Tagged ORFs
- Yeast TAP Tagged ORFs Collection
- Yeast Tet Promoters Hughes Collection yTHC
- Yeast Tet Promoters Hughes yTHC
- Yeast YFP Fusion Kinase Collection
- Zebrafish
- Zebrafish Collection
- non mammalian cdnas and orfs
- ordering instructions for non-mammalian clones
- c elegans
- e coli
- yeast
-
PIFs
-
transfection and ancillary reagents
-
PIFs
- 10 mM Tris HCl Buffer pH 7 4
- 5X siRNA Buffer
- Accell siRNA Delivery Media
- DharmaFECT 1 Transfection Reagent
- DharmaFECT 2 Transfection Reagent
- DharmaFECT 3 Transfection Reagent
- DharmaFECT 4 Transfection Reagent
- DharmaFECT Duo Transfection Reagent
- DharmaFECT kb DNA transfection reagent
- DharmaFECT Set of 4 Transfection Reagents
- TOX Transfection Control
- RNase free Water
- siGLO Cyclophilin B Control siRNA
- siGLO Green Transfection Indicator
- siGLO Lamin A C Control siRNA Human
- siGLO Lamin A C Control siRNA Mouse
- siGLO Lamin A C Control siRNA Rat
- siGLO Lamin A C siRNA Human Mouse Rat
- siGLO Red Transfection Indicator
- siGLO RISC Free Control
- ancillary reagents
- dharmafect cell type guide
- transfection
- viral packaging
-
PIFs
-
knockdown reagents
-
screening
-
cell panel screening
-
chalice bioinformatics software
-
chalice analyzer
-
chalice viewer
-
reviewing data
-
chalice analyzer
- custom drug combination screens
- drug combination screening
- high throughput combination screening for epigenetic modifiers
-
immunology assay screens
- cytotoxicity assays
- adcc and cdc assays
- analysis of apoptotic pathways by western blot
- apoptosis assays
- cell proliferation assay service
- flow cytometry analysis of apoptotic markers
- immune suppression assays
- kinetic analysis of apoptosis
- kinetic imaging assay service
- mdsc supression assay
- mixed lymphocyte reaction
- proliferation assays
- signal transduction assay service
- t cell activation assay
- t cell mediated tumor cell lysis assay
- t cell proliferation assays
- treg suppression assay
- oncoreference data set
- Oncosignature cell panel screening service
-
chalice bioinformatics software
-
functional genomic screening
-
screening libraries
-
Gene editing screening libraries
-
Gene modulation screening libraries
- rnai screening libraries
- cherry pick clone libraries
- cherry pick libraries
- custom pooled lentiviral screening libraries
- pooled lentiviral screening libraries
-
crispra libraries
-
siRNA
-
PIFs
- Human Accell siRNA Library Phosphatases
- Human Accell siRNA Library Deubiquitinating Enzymes
- Human Accell siRNA Library DNA Damage Response
- Human Accell siRNA Library Drug Targets
- Human Accell siRNA Library Druggable Genome
- Human Accell siRNA Library Epigenetics
- Human Accell siRNA Library G Protein Coupled Receptors GPCR
- Human Accell siRNA Library Ion Channels
- Human Accell siRNA Library Proteases
- Human Accell siRNA Library Protein Kinase
- Human Accell siRNA Library Transcription Factors
- Human Accell siRNA Library Tyrosine Kinases
- Human Accell siRNA Library Ubiquitin Enzymes
- Mouse Accell siRNA Library Protein Kinases
- Human ON TARGETplus RTF Cell Cycle Regulation
- Human ON TARGETplus RTF Cytokine Receptors
- Human ON TARGETplus RTF Deubiquitinating Enzymes
- Human ON TARGETplus RTF DNA Damage Response
- Human ON TARGETplus RTF Epigenetics
- Human ON TARGETplus RTF GPCR
- Human ON TARGETplus RTF Ion Channels
- Human ON TARGETplus RTF Membrane Trafficking
- Human ON TARGETplus RTF Nuclear Receptors
- Human ON TARGETplus RTF Phosphatases
- Human ON TARGETplus RTF Proteases
- Human ON TARGETplus RTF Protein Kinase
- Human ON TARGETplus RTF Transcription Factors
- Human ON TARGETplus RTF Tyrosine Kinases
- Human ON TARGETplus RTF Ubiquitin Conjugation Subset 1
- Human ON TARGETplus RTF Ubiquitin Conjugation Subset 2
- Human ON TARGETplus RTF Ubiquitin Conjugation Subset 3
- Human RTF Optimization Plates ON TARGETplus
- Human ON TARGETplus siRNA Library Apoptosis
- Human ON TARGETplus siRNA Library Cell Cycle Regulation
- Human ON TARGETplus siRNA Library Cytokine Receptors
- Human ON TARGETplus siRNA Library Deubiquitinating Enzymes
- Human ON TARGETplus siRNA Library DNA Damage Response
- Human ON TARGETplus siRNA Library Drug Targets
- Human ON TARGETplus siRNA Library Druggable Genome
- Human ON TARGETplus siRNA Library Epigenetics
- Human ON TARGETplus siRNA Library G Protein coupled Receptors
- Human ON TARGETplus siRNA Library Genome
- Human ON TARGETplus siRNA Library Ion Channels
- Human ON TARGETplus siRNA Library Membrane Trafficking
- Human ON TARGETplus siRNA Library Nuclear Receptors
- Human ON TARGETplus siRNA Library Phosphatases
- Human ON TARGETplus siRNA Library Proteases
- Human ON TARGETplus siRNA Library Protein Kinases
- Human ON TARGETplus siRNA Library Transcription Factors
- Human ON TARGETplus siRNA Library Tyrosine Kinases
- Human ON TARGETplus siRNA Library Ubiquitin Conjugation Subset 1
- Human ON TARGETplus siRNA Library Ubiquitin Conjugation Subset 2
- Human ON TARGETplus siRNA Library Ubiquitin Conjugation Subset 3
- Human ON TARGETplus siRNA Library Ubiquitin Enzymes
- Mouse RTF Optimization plates ON TARGETplus
- Mouse ON TARGETplus RTF Apoptosis
- Mouse ON TARGETplus RTF Cell Cycle Regulation
- Mouse ON TARGETplus RTF Cytokine Receptors
- Mouse ON TARGETplus RTF Deubiquitinating Enzymes
- Mouse On TARGETplus RTF Epigenetics
- Mouse ON TARGETplus RTF G Protein Coupled Receptors
- Mouse ON TARGETplus RTF Ion Channels
- Mouse ON TARGETplus RTF Membrane Trafficking
- Mouse ON TARGETplus RTF Nuclear Receptors
- Mouse ON TARGETplus RTF Phosphatases
- Mouse ON TARGETplus RTF Proteases
- Mouse ON TARGETplus RTF Protein Kinases
- Mouse ON TARGETplus RTF Tyrosine Kinases
- Mouse ON TARGETplus RTF Ubiquitin Conjugation Subset 1
- Mouse ON TARGETplus RTF Ubiquitin Conjugation Subset 2
- Mouse ON TARGETplus RTF Ubiquitin Conjugation Subset 3
- Mouse ON TARGETplus siRNA Library Apoptosis
- Mouse ON TARGETplus siRNA Library Cell Cycle Regulation
- Mouse ON TARGETplus siRNA Library Cytokine Receptors
- Mouse ON TARGETplus siRNA Library Deubiquitinating Enzyme
- Mouse ON TARGETplus siRNA Library Drug Targets
- Mouse ON TARGETplus siRNA Library Druggable Genome
- Mouse On TARGETplus siRNA Library Epigenetics
- Mouse ON TARGETplus siRNA Library G Protein Coupled Receptor
- Mouse ON TARGETplus siRNA Library Ion Channels
- Mouse ON TARGETplus siRNA Library Membrane Trafficking
- Mouse ON TARGETplus siRNA Library Nuclear Receptors
- Mouse ON TARGETplus siRNA Library Phosphatase
- Mouse ON TARGETplus siRNA Library Proteases
- Mouse ON TARGETplus siRNA Library Protein Kinases
- Mouse ON TARGETplus siRNA Library Serine Proteases
- Mouse ON TARGETplus siRNA Library Transcription Factors
- Mouse ON TARGETplus siRNA Library Tyrosine Kinases
- Mouse ON TARGETplus siRNA Library Ubiquitin Conjugation Subset 1
- Mouse ON TARGETplus siRNA Library Ubiquitin Conjugation Subset 2
- Mouse ON TARGETplus siRNA Library Ubiquitin Conjugation Subset 3
- Human siGENOME RTF Apoptosis
- Human siGENOME RTF Calcium Calmodulin Protein Kinase
- Human siGENOME RTF Cell Cycle Regulation
- Human siGENOME RTF Cytokine Receptors
- Human siGENOME RTF Deubiquitinating Enzymes
- Human siGENOME RTF DNA Damage Response
- Human siGENOME RTF G Protein coupled Receptors
- Human siGENOME RTF Ion Channels
- Human siGENOME RTF Library Epigenetics
- Human siGENOME RTF Membrane Trafficking
- Human siGENOME RTF Nuclear Receptors
- Human siGENOME RTF Phosphatases
- Human siGENOME RTF Proteases
- Human siGENOME RTF Protein Kinases
- Human siGENOME RTF Serine Proteases
- Human siGENOME RTF Transcription Factors
- Human siGENOME RTF Tyrosine Kinases
- Human siGENOME RTF Ubiquitin Conjugation Subset 1
- Human siGENOME RTF Ubiquitin Conjugation Subset 2
- Human siGENOME RTF Ubiquitin Conjugation subset 3
- Human Mouse RTF Optimization Plates ON TARGETplus
- Human siGENOME siRNA Library Apoptosis
- Human siGENOME siRNA Library Cell Cycle Regulation
- Human siGENOME siRNA Library Cytokine Receptors
- Human siGENOME siRNA Library Deubiquitinating Enzymes
- Human siGENOME siRNA Library DNA Damage Response
- Human siGENOME siRNA Library Drug Targets
- Human siGENOME siRNA Library Druggable Genome
- Human siGENOME siRNA Library Epigenetics
- Human siGENOME siRNA Library G Protein Coupled Receptors
- Human siGENOME siRNA Library Genome
- Human siGENOME siRNA Library Ion Channels
- Human siGENOME siRNA Library Membrane Trafficking
- Human siGENOME siRNA Library Nuclear Receptors
- Human siGENOME siRNA Library Phosphatases
- Human siGENOME siRNA Library Proteases
- Human siGENOME siRNA Library Protein Kinases
- Human siGENOME siRNA Library Serine Proteases
- Human siGENOME siRNA Library STE Kinases
- Human siGENOME siRNA Library Transcription Factors
- Human siGENOME siRNA Library Tyrosine Kinases
- Human siGENOME siRNA Library Ubiquitin Conjugation Subset 1
- Human siGENOME siRNA Library Ubiquitin Conjugation Subset 2
- Human siGENOME siRNA Library Ubiquitin Conjugation Subset 3
- Human siGENOME siRNA Library Ubiquitin Enzymes
- Mouse siGENOME RTF Apoptosis
- Mouse siGENOME RTF Cell Cycle Regulation
- Mouse siGENOME RTF Cytokine Receptors
- Mouse siGENOME RTF Deubiquitinating Enzymes
- Mouse siGENOME RTF Epigenetics
- Mouse siGENOME RTF G Protein coupled Receptors
- Mouse siGENOME RTF Ion Channels
- Mouse siGENOME RTF Membrane Trafficking
- Mouse siGENOME RTF Nuclear Receptors
- Mouse siGENOME RTF Phosphatases
- Mouse siGENOME RTF Proteases
- Mouse siGENOME RTF Protein Kinases
- Mouse siGENOME RTF Tyrosine Kinase
- Mouse siGENOME RTF Ubiquitin Conjugation Subset 1
- Mouse siGENOME RTF Ubiquitin Conjugation Subset 2
- Mouse siGENOME RTF Ubiquitin Conjugation Subset 3
- Mouse siGENOME siRNA Library Apoptosis
- Mouse siGENOME siRNA Library Cell Cycle Regulation
- Mouse siGENOME siRNA Library Cytokine Receptors
- Mouse siGENOME siRNA Library Deubiquinating Enzymes
- Mouse siGENOME siRNA Library Drug Targets
- Mouse siGENOME siRNA Library Druggable Genome
- Mouse siGENOME siRNA Library Epigenetics
- Mouse siGENOME siRNA Library G Protein Coupled Receptors
- Mouse siGENOME siRNA Library Genome
- Mouse siGENOME siRNA Library Ion Channels
- Mouse siGENOME siRNA Library Membrane Trafficking
- Mouse siGENOME siRNA Library Nuclear Receptors
- Mouse siGENOME siRNA Library Phosphatases
- Mouse siGENOME siRNA Library Proteases
- Mouse siGENOME siRNA Library Protein Kinases
- Mouse siGENOME siRNA Library Serine Proteases
- Mouse siGENOME siRNA Library Transcription Factors
- Mouse siGENOME siRNA Library Tyrosine Kinases
- Mouse siGENOME siRNA Library Ubiquitin Conjugation Subset 1
- Mouse siGENOME siRNA Library Ubiquitin Conjugation Subset 2
- Mouse siGENOME siRNA Library Ubiquitin Conjugation Subset 3
- Human Lincode siRNA Library
- Mouse Lincode siRNA Library
- Human Duet siRNA Library Drug Targets
- Human Duet siRNA Library Druggable Genome
- Human Duet siRNA Library Epigenetics
- Human Duet siRNA Library Genome
- human sirna libraries
- mouse sirna libraries
- rtf sirna libraries
-
PIFs
-
shRNA
-
PIFs
- Decode Pooled Lentiviral shRNA Screening Libraries and Reagents
- GIPZ Lentiviral shRNA Gene Family and Pathway Libraries
- GIPZ Lentiviral shRNA Libraries
- SMARTvector Inducible Lentiviral shRNA Pooled Libraries
- SMARTvector Lentiviral shRNA Pooled Libraries
- TRC Lentiviral shRNA Gene Family and Pathway Libraries
- TRC Lentiviral shRNA Library
- TRIPZ Inducible Lentiviral shRNA Libraries
- gipz lentiviral shrna libraries
- trc lentiviral shrna libraries
-
PIFs
-
miRNA
- genomic screening libraries
-
Gene editing screening libraries
- in vitro assay services
- why work with us
-
cell panel screening
-
tools
-
landing pages
- Cherry pick library loader
- CRISPR Design Tool
- CRISPR DNA Region Designer
- CRISPR Guide RNA Designer
- crispr specificity analysis
- CRISPR Targeted Gene Designer
- Custom miRNA
- Custom siRNA
- Custom SMARTpool
- DNA copy number calculation
- Edit R HDR Donor Designer plasmid
- Edit R HDR Donor Designer oligo
- Multiple primer analyzer
- nmol to ug Calculator
- OD conversion
- Order Multiple Single strand DNA
- Order Multiple Single strand RNA
- Order Single strand DNA
- Order Single strand RNA
- P value to Z score Converter
- siDESIGN Center
- T7EI Calculator
- TM Calculator
-
landing pages
- promos
- resources
- search
- home page